Effect of miRNA-136-5p on inflammatory factors in rat models of acute spinal cord injury

doi:10.3969/j.issn.2095-4344.1173

Abstract

Abstract:

BACKGROUND: miRNA-136-5p plays a crucial regulatory role in pathological changes, inflammatory response and regeneration after spinal cord injury.
OBJECTIVE: To investigate the effect of miRNA-136-5p on the expression of cytokines in serum and NF-κB protein in spinal cord in rats with spinal cord injury and to explore the molecular mechanism.
METHODS: Thirty-six male Sprague-Dawley rats, of SPF grade were provided by Laboratory Animal Center of Guangxi Medical University. The lentiviral vector system was prepared and transfected into spinal cord injured rats. Thirty-six rat models of spinal cord injury were established by modified Allen’s method. Basso Beattie Bresnahan scores were performed. Rats were randomly divided into normal control, modeling (LV-ctrl plus spinal cord injury), overexpression (spinal cord injury plus LV-miRNA-136-5p), and inhibition (spinal cord injury plus LV-sponge) groups (n=9/group). Seven days before surgery and the day of surgery, the overexpression and inhibition groups were continuously injected with the lentivirus suspension into the injured area, and the normal control and modeling groups were injected with the same amount of normal saline. Three rats were sacrificed at 1, 3 and 7 days, and blood and spinal cord tissues were taken. The levels of interleukin-1β, interleukion-6 and interferon-α in rat serum were determined by ELISA. The expression of NF-κB protein was detected by western blot assay and double immunofluorescence.
RESULTS AND CONCLUSION: (1) There was no significant difference in preoperative Basso Beattie Bresnahan scores (P > 0.05). In the modeling group, the rats showed prone walking, vary degrees of urinary retention, and spinal shock, with complete loss of function of both hind limbs and muscle strength of 0. (2) Compared with the normal control group, the levels of inflammatory factors in the other groups were increased significantly (P < 0.05). The expression levels of inflammatory factors were highest in the overexpression group, followed by modeling group, and lowest in the inhibition group. (3) Results of western blot assay and double immunofluorescence showed that the expression level of NF-κB protein in the modeling, overexpression and inhibition groups was significantly higher than that in the normal control group (P < 0.05), and the level was highest in the overexpression group. (4) In summary, miRNA-136-5p can affect inflammatory factors and NF-κB in rats with acute spinal cord injury.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: MicroRNAs, Spinal Cord Injuries, NF-kappa B, Tissue Engineering

CLC Number:

R446，R318

Deng Guiying, Zeng Gaofeng, Cen Zhongxi, Gao Yunbing, Cao Baichuan, Huang Jianhua, Zong Shaohui. Effect of miRNA-136-5p on inflammatory factors in rat models of acute spinal cord injury[J]. Chinese Journal of Tissue Engineering Research, 2019, 23(15): 2397-2402.

Figures/Tables 5

References

[1] 杨俊松,郝定均,刘团江,等.急性脊髓损伤的临床治疗进展[J].中国脊柱脊髓杂志,2018,28(4):368-373.

[2] Böthig R, Fiebag K, Thietje R,et al. Morbidity of urinary tract infection after urodynamic examination of hospitalized SCI patients: the impact of bladder management. Spinal cord. 2013;51(1):70-73.

[3] 梁锦前,沈建雄,邱贵兴.干细胞移植修复脊髓损伤的研究进展[J].中国脊柱脊髓杂志, 2008, 18(6): 475478．

[4] Kwon BK,Dyomk MF,Fisher CG,et al.Spinal cord injury regene rative strategies and obstacles.Curr 0pin 0rthop.2004;15(3): 196-201．

[5] Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature.2011;474(7350): 212-215.

[6] van Solingen C, Seghers L, Bijkerk R,et al. Antagomir- mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009;13(8A):1577-1585.

[7] Ma X,Zhou J,Zhong Y,et al.Expression, regulation and function of microRNAs in multiple sclerosis.Int J Med Sci. 2014;11(8):810-818.

[8] Ksiazekwiniarek DJ, Kacperska MJ, Glabinski A.MicroRNAs as Novel Regulators of Neuroinflammation. Mediators Inflamm 2013;2013:519-530.

[9] Lee HK,Bier A, Cazacu S, et al.MicroRNA-145 is downregulated in glial tumorsand and regulates glioma cell migration by targeting connective tissue growth factor. Plos One.2013;8:e54652.

[10] Wang XH, Wang TL.MicroRNAs of microglia: Wrestling with central nervous system disease.Neural Regen Res. 2018; 13(12):2067-2072.

[11] Nishida N, Nagahara M, Sato T, et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res. 2012;18(11): 3054-3070.

[12] Visone R, Russo L, Pallante P,et al. MicroRNAs miR-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.Endocrine-Related Cancer. 2007; 14(3): 791-798.

[13] Chen HY, Lin YM, Chung HC, et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012;72(14): 3631-3641.

[14] Schulte LN, Westermann AJ, Vogel J. Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. Nucleic Acids Res. 2013;41(1): 542-553.

[15] Psathas JN, Doonan PJ, Raman P, et al. The Myc-miR-1792 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood. 2013; 122(26): 4220-4229.

[16] Zardo G, Ciolfi A, Vian L, et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood. 2012; 119(17): 4034-4046.

[17] Siddle KJ, Deschamps M, Tailleux L, et al. A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection. Genome research. 2014; 24(5): 850-859.

[18] 程素利,徐家淳,王剑歌,等.急性脊髓损伤大鼠Allen's造模方法的改良及行为学评价[J].四川中医,2015,33(10):43-45.

[19] Kozomara A, Griffiths-Jones S. mi RBase: integrating micro RNA annotation and deep-sequencing data. Nucleic Acids Res.2011;39(Database issue): D152-157.

[20] Zhou X, Jeker LT, Fife BT. Selective mi RNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med. 2008; 205(9): 1983-1991.

[21] Bak M, Silahtaroglu A, Møller M, et al. MicroRNA expression in the adult mouse central nervous system.RNA (New York, N.Y.).2008;14(3): 432-444.

[22] Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004; 116(2):281-297.

[23] Pauley KM,Cha S,Chan EK.MicroRNA in autoimmunity and autoimmune diseases.(New York, N.Y.)J Autoimmun.2009; 32(3-4):189-194.

[24] 杨俊娜,何丽,徐陶,等.miR-124在神经系统发育、损伤及修复中作用的研究进展[J].山东医药,2018,58(20):100-103.

[25] 田密,丁宇,侯德仁,等.实时荧光定量PCR检测转基因阿尔茨海默病小鼠脑组织中miRNAs的差异表达[J].南方医科大学学报, 2013,33(2):262-266.

[26] 孔程程,杨文平,华建,等.血清miRNA-181a在帕金森病中神经保护作用及机制分析[J].南京医科大学学报(自然科学版), 2017, 37(9):1081-1085.

[27] Shi XZ,Zong SH,He JC,et al. miR-136-5p effect on A20 expression in interleukin-17-stimulated astrocytes. Zhongguo Zuzhi Gongcheng Yanjiu. 2017;21(16):2587-2592.

[28] Bortolotto V, Grilli M.Novel insights into the role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells.Neural Regen Res. 2017;12(3):354-357.

[29] Strickland ER, Hook MA, Balaraman S, et al.MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair. Neuroscience. 2011;186:146-160.

[30] Aoki E,Yano R,Yokoyama H,et al.Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP-induced apoptosis in nigral neurons of mice. Experimental and Molecular Pathlogy 2009;86:57-64.

[31] Ahn KS, Sethi G, Aggarwal BB: Nuclear factor-kappa B: from clone to clinic. Current Mol Med 2007;7:619-637

[32] Sohn KH, Jo JM, Cho WJ, et al. Bojesodok-eum, a herbal prescription, ameliorates acute inflammation in association with the inhibition of NF-κB-mediated nitric oxide and proinflammatory cytokine production.Evid-Based Complement Alternat Med. 2012: 457370.

[33] Cortez M, Carmo LS, Rogero MM, et al. A high-fat diet increases IL-1, IL-6, and TNF-α production by increasing NF-κB and attenuating PPAR-γ expression in bone marrow mesenchymal stem cells.Inflammation.2013;36: 379−386.

[34] Jobin C, Sartor RB. NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm Bowel Dis. 2000; 6: 206−213.

[35] He J, Zhao J, Peng X,et al. Molecular Mechanism of MiR-136-5p Targeting NF-κB/A20 in the IL-17-Mediated Inflammatory Response after Spinal Cord Injury. Cell Physiol Biochem. 2017;44(3):1224-1241.